CULLINAN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.1 USD | +4.04% |
|
+48.76% | +175.76% |
| 29/04 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
| 29/04 | Cullinan Therapeutics, Inc Appoints Mary Kay Fenton as Chief Financial Officer | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 26/04/2024 | 29/04/2024 | 30/04/2024 | 01/05/2024 | |
|---|---|---|---|---|
| Last | 25.3 $ | 27.12 $ | 27.01 $ | 28.1 $ |
| Volume | 4 747 718 | 2 703 008 | 1 420 120 | 1 442 282 |
| Change | +31.43% | +7.19% | -0.41% | +4.04% |
| Opening | 19.27 | 25.62 | 27.15 | 27.54 |
| High | 25.72 | 29.12 | 28.03 | 28.99 |
| Low | 19.27 | 25.60 | 26.34 | 27.30 |
Performance
| 1 day | +4.04% | ||
| 1 week | +48.76% | ||
| Current month | +4.04% | ||
| 1 month | +59.21% | ||
| 3 months | +60.48% | ||
| 6 months | +202.80% | ||
| Current year | +175.76% | ||
| 1 year | +173.08% | ||
| 3 years | -13.43% |
Volumes
marketsDaily volume
1 442 282
Estimated daily volume
1 442 282
Avg. Volume 20 sessions
1 391 652
Daily volume ratio
1.04
Avg. Volume 20 sessions USD
39 105 421.20
Record volume 1
14 668 600
Record volume 2
4 747 718
Record volume 3
4 054 268
Capital turnover ratio
0.03
Float rotation
0.03
Basic data
Capitalization (USD)
1 210 144 624
Net sales (USD)
0
Number of employees
85
Sales / Employee (USD)
0
Free-Float
93.6 %
Free-Float capitalization (USD)
1 132 733 199
Average Daily Capital Traded
3.23%
Highs and lows
1 week
19.27
29.12
1 month
15.2029.12
Current year
10.0029.12
1 year
7.6429.12
3 years
7.3037.66
5 years
7.3059.85
10 years
7.3059.85
Indicators
Moving average 5 days
25.36
Moving average 20 days
18.57
Moving average 50 days
17.70
Moving average 100 days
15.20
Price spread / (MMA5)
-9.77%
Price spread / (MMA20)
-33.92%
Price spread / (MMA50)
-37.02%
Price spread / (MMA100)
-45.91%
STIM
RSI 9 days
85.11
RSI 14 days
80.32
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.04% | +48.76% | +175.76% | +173.08% | 1.21B | ||
| +0.50% | -3.28% | +0.67% | +22.60% | 42.4B | ||
| -2.30% | +0.71% | +44.30% | -7.84% | 40.04B | ||
| +2.89% | +5.76% | -6.20% | +17.68% | 28.31B | ||
| +1.25% | -2.53% | +6.55% | +54.32% | 24.94B | ||
| +4.18% | +4.28% | -21.66% | -25.71% | 18.96B | ||
| +2.58% | +0.21% | +29.96% | +92.93% | 12.3B | ||
| +1.61% | -2.82% | -1.57% | +22.40% | 11.95B | ||
| +8.88% | +7.65% | +16.03% | +9.92% | 11.32B | ||
| +16.22% | +15.65% | -4.80% | -7.28% | 11.55B | ||
| +1.13% | +3.11% | -4.38% | -7.23% | 9.5B | ||
| -0.94% | +18.86% | +7.53% | -35.02% | 6.6B | ||
| -1.29% | +2.23% | +23.31% | -17.46% | 6.54B | ||
| +4.09% | +9.03% | +35.30% | +62.70% | 6.62B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| +4.24% | +1.32% | -14.98% | +20.54% | 6.27B | ||
| Average | +2.94% | +5.92% | +19.06% | +25.04% | ||
| Weighted average by Cap. | +2.10% | +1.53% | +9.93% | +15.89% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
c4c0c7.pSTIdDvbAjLkURkUKPs2mg5mczlbQCobMT6-kTl46NQ.nXv-MVe5amWMZlxXEJB32UkTNEoZOUQrfWHf5HcInZX0aoNFUpVmdqgzLQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 01:30:00 am | 28.1 | 93,215 | 1,010,770 |
| 01:30:00 am | 28.08 | 200 | 917,555 |
| 01:29:59 am | 28.1 | 100 | 917,355 |
| 01:29:59 am | 28.07 | 185 | 917,255 |
| 01:29:59 am | 28.09 | 100 | 917,070 |
| 01:29:59 am | 28.07 | 100 | 916,970 |
| 01:29:58 am | 28.06 | 100 | 916,870 |
| 01:29:57 am | 28.08 | 100 | 916,770 |
| 01:29:57 am | 28.06 | 100 | 916,670 |
| 01:29:56 am | 28.06 | 100 | 916,570 |
Monthly variations
Annual change
| 2024 | +175.76% | ||
| 2023 | -3.41% | ||
| 2022 | -31.63% | ||
| 2021 | -48.41% |
- Stock Market
- Equities
- CGEM Stock
- Quotes Cullinan Therapeutics, Inc.
